Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • 4SC board of directors update

    4SC AG (Xetra:VSC), Planegg-Martinsried, Germany Business: Autoimmune, Cancer Hired: Erich Enghofer as EVP of oncology and hematology, a newly created position, formerly head of the oncology business unit at Bayer AGs …

    Published on 7/21/2014
  • Acadia Pharmaceuticals board of directors update

    Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), San Diego, Calif. Business: Neurology, Ophthalmic Hired: Stephen Davis as EVP, CFO and CBO, formerly EVP and COO of Heron Therapeutics Inc.

    Published on 7/21/2014
  • Achaogen board of directors update

    Achaogen Inc. (NASDAQ:AKAO), South San Francisco, Calif. Business: Infectious Hired: Ian Friedland as CMO, formerly VP of clinical development at Cubist Pharmaceuticals Inc.

    Published on 7/21/2014
  • ContraVir Pharmaceuticals board of directors update

    ContraVir Pharmaceuticals Inc. (OTCBB:CTRV), New York, N.Y. Business: Infectious Hired: William Hornung as CFO, formerly VP of finance at PTC Therapeutics Inc.

    Published on 7/21/2014
  • Edico Genome board of directors update

    Edico Genome Inc., La Jolla, Calif. Business: Genomics Appointed: Greg Lucier, formerly chairman and CEO of Life Technologies Corp., which Thermo Fisher Scientific Inc. acquired

    Published on 7/21/2014
  • Glide Pharma board of directors update

    Glide Pharma Technologies Ltd., Abingdon, U.K. Business: Drug delivery Hired: Richard Bungay as CFO

    Published on 7/21/2014
  • Illumina board of directors update

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Business: Microarrays, Genomics, Supply/Service Hired: Tina Nova as SVP and general manager of Illuminas oncology business, formerly president and CEO of Genoptix Inc, …

    Published on 7/21/2014
  • IntelGenx board of directors update

    IntelGenx Corp. (TSX-V:IGX; OTCQX:IGXT), Saint-Laurent, Quebec Business: Drug delivery Transitioned: Horst Zerbe to interim president and CEO, while remaining chairman; he replaces Rajiv Khosla, who resigned as …

    Published on 7/21/2014
  • Intezyne board of directors update

    Intezyne Technologies Inc., Tampa, Fla. Business: Cancer Hired: Tim Coan as CFO, formerly a partner at Deerfield Partners; and Carolyn Paradise as acting CMO, formerly president and COO of Armgo Pharma Inc.

    Published on 7/21/2014
  • ISA Pharmaceuticals board of directors update

    ISA Pharmaceuticals B.V., Leiden, the Netherlands Business: Cancer, Infectious Transitioned: Ronald Loggers to CEO from acting CEO

    Published on 7/21/2014
  • Lexicon board of directors update

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas Business: Gastrointestinal, Autoimmune, Functional genomics Hired: Lonnel Coats as president, CEO and a director, formerly president and CEO of Eisai Co. …

    Published on 7/21/2014
  • Loxo board of directors update

    Loxo Oncology Inc., Stamford, Conn. Business: Cancer Hired: Dov Goldstein, a director, as CFO; and Jennifer Low as EVP of R&D, formerly senior group medical director in product development at the Genentech Inc. unit of …

    Published on 7/21/2014
  • Medivation board of directors update

    Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Business: Cancer Departed: Cheryl Cohen as chief commercial officer; she is replaced on an interim basis by Dawn Svoronos, a director and former president of Europe …

    Published on 7/21/2014
  • Merck KGaA board of directors update

    Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Pharmaceuticals, Other Hired: Luciano Rossetti as EVP and global head of R&D, formerly SVP of late stage development at Merck & Co. Inc.; he succeeds the President …

    Published on 7/21/2014
  • Minerva Neurosciences board of directors update

    Minerva Neurosciences Inc. (NASDAQ:NERV), Cambridge, Mass. Business: Neurology Hired: Frederick Ahlholm as VP of finance and chief accounting officer, formerly VP of finance and chief accounting officer of Amarin Corp. …

    Published on 7/21/2014
  • Novartis board of directors update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals Transitioning: Eric Cornut to chief ethics, compliance and policy officer, effective Aug. 1, from chief commercial officer at Novartis …

    Published on 7/21/2014
  • Piedmont board of directors update

    Piedmont Pharmaceuticals LLC, Greensboro, N.C. Business: Infectious, Veterinary Appointed: Dennis Steadman, founder and former CEO of Velcera Inc., which Perrigo Co. plc aquired, as chairman

    Published on 7/21/2014
  • Provista Diagnostics board of directors update

    Provista Diagnostics Inc., New York, N.Y. Business: Diagnostic Hired: Rao Mulpuri as COO, formerly VP of laboratory operations at AssureRx Health Inc.

    Published on 7/21/2014
  • QRxPharma board of directors update

    QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY), North Sydney, Australia Business: Neurology Resigned: Peter Farrell as chairman MANAGEMENT

    Published on 7/21/2014
  • Raptor board of directors update

    Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif. Business: Neurology, Endocrine/Metabolic, Renal Transitioned: Julie Anne Smith to president, effective immediately, and to CEO and a director, effective Jan. 1,…

    Published on 7/21/2014
  • Repligen board of directors update

    Repligen Corp. (NASDAQ:RGEN), Waltham, Mass. Business: Biomanufacturing, Supply/Service Hired: Jon Snodgres as CFO, formerly CFO of Maquet Holding B.V. & Co. KG

    Published on 7/21/2014
  • Theravance board of directors update

    Theravance Inc. (NASDAQ:THRX), South San Francisco, Calif. Business: Infectious, Gastrointestinal, Pulmonary Hired: Theodore Witek as SVP of corporate partnerships, clinical and medical affairs, formerly president and …

    Published on 7/21/2014
  • Topotarget board of directors update

    Topotarget A/S (CSE:TOPO), Copenhagen, Denmark Business: Cancer Resigning: Anders Vadsholt as CEO, effective July 31 or until the approval of Topotargets merger with BioAlliance Pharma S.A.; BioAlliance CEO Judith …

    Published on 7/21/2014
  • Transition Therapeutics board of directors update

    Transition Therapeutics Inc. (TSX:TTH; NASDAQ:TTHI), Toronto, Ontario Business: Endocrine/Metabolic, Neurology Transitioned: Carl Damiani to COO from VP of business development

    Published on 7/21/2014
  • Vertex board of directors update

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Infectious, Autoimmune, Pulmonary Retiring: Peter Mueller as EVP of global R&D and CSO, effective Oct. 31

    Published on 7/21/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993